The Nasdaq Biotechnology Index rose over 2.4%, outperforming the broader U.S. stock market. Novavax increased by 20.67%, while Ironwood Pharma, Moderna, Vir Biotechnology, BioNTech, Annexon, and Aura Biosciences saw gains between 15.94% and 10.26%. Solid Biosciences rose by 9.61%. In contrast, Zenas Biopharma fell by 6.18%, PepGen dropped by 9.08%, and Legend Biotech decreased by 11.40%Wallstreetcn·Jan 21, 2026 at 09:39 PMBBH-2.08%IBBQ-2.73%
The Nasdaq Biotechnology Index rose over 1% in early trading of U.S. stocks. Among the constituent stocks, Annexon rose 14.04%, Design Therapeutics rose 15.80%, Adaptive Biotechnologies rose 10.89%, Alumis rose 10.27%, and Agios Pharmaceuticals rose 9.44%. Biogen fell 0.97%, Amgen fell 1.28%, Applied Therapeutics fell 2.32%, and Arrowhead Pharmaceuticals fell 2.79%Wallstreetcn·Nov 20, 2025 at 02:41 PMDSGN-1.62%ADPT-6.10%
The Nasdaq Biotechnology Index closed up nearly 1.5%Wallstreetcn·Sep 26, 2025 at 08:31 PMANNX-5.28%PEPG+2.77%
